|
|
|
Insider
Information: |
Bock Louis C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
27,677 |
|
Indirect Shares
|
8,257,217 |
|
|
Direct
Value |
$147 |
|
|
Indirect Value
|
$64,822,855 |
|
|
Total
Shares |
8,284,894 |
|
|
Total
Value |
$64,823,002 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dynavax Technologies Corp |
DVAX |
Director |
2004-02-19 |
0 |
2004-02-24 |
213,915 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director, 10% Owner |
2005-12-20 |
0 |
2005-12-20 |
1,965,286 |
Premium* |
|
Sgx Pharmaceuticals, Inc. |
SGXP |
Director, 10% Owner |
2006-02-06 |
0 |
2008-08-20 |
0 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
Director |
2014-11-18 |
27,677 |
2014-11-18 |
700 |
Premium* |
|
Diadexus Inc |
DDXS |
Director |
|
0 |
2010-07-28 |
3,872,851 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
Director |
2010-11-29 |
0 |
2018-03-12 |
0 |
Premium* |
|
Horizon Pharma, Inc. |
HZNP |
Director |
2011-08-02 |
0 |
2011-08-02 |
2,204,465 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
28 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DVAX |
Dynavax Technologies Corp |
Director |
|
2004-02-19 |
4 |
A |
$7.50 |
$149,963 |
I/I |
19,995 |
19,995 |
|
- |
|
DVAX |
Dynavax Technologies Corp |
Director |
|
2004-02-24 |
4 |
A |
$0.00 |
$0 |
I/I |
193,920 |
213,915 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
|
2005-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,965,286 |
1,965,286 |
|
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
officerTitle |
|
2006-02-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,046,747 |
2,046,747 |
|
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
Director |
|
2006-02-06 |
4/A |
B |
$6.00 |
$3,000,000 |
I/I |
500,000 |
2,546,747 |
2.25 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-05-01 |
4 |
A |
$0.00 |
$0 |
I/I |
2,797,424 |
2,797,424 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-11-14 |
4 |
S |
$15.96 |
$8,280 |
I/I |
(518) |
2,796,906 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-11-15 |
4 |
S |
$15.22 |
$221,418 |
I/I |
(14,206) |
2,768,405 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-11-15 |
4 |
S |
$15.38 |
$23,356 |
I/I |
(1,499) |
2,766,906 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-11-15 |
4 |
S |
$15.36 |
$221,889 |
I/I |
(14,295) |
2,782,611 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-11-16 |
4 |
S |
$15.41 |
$250,682 |
I/I |
(16,142) |
2,720,345 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-11-16 |
4 |
S |
$15.59 |
$476,485 |
I/I |
(30,419) |
2,736,487 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-11-19 |
4 |
S |
$15.00 |
$33,061 |
I/I |
(2,200) |
2,718,145 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-11-20 |
4 |
S |
$15.00 |
$9,000 |
I/I |
(600) |
2,717,545 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-11-21 |
4 |
S |
$15.00 |
$1,500 |
I/I |
(100) |
2,717,445 |
0 |
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
Director |
|
2008-08-20 |
4 |
D |
$3.00 |
$7,640,241 |
I/I |
(2,546,747) |
0 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2009-07-27 |
4 |
S |
$7.50 |
$2,250,000 |
I/I |
(300,000) |
3,017,445 |
0 |
- |
|
ZGNX |
Zogenix, Inc. |
Director |
|
2010-11-29 |
4 |
A |
$0.00 |
$0 |
I/I |
2,231,901 |
2,231,901 |
0 |
- |
|
ZGNX |
Zogenix, Inc. |
Director |
|
2010-11-29 |
4 |
B |
$4.00 |
$7,358,580 |
I/I |
1,839,645 |
4,071,546 |
2.25 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2011-08-02 |
4 |
A |
$0.00 |
$3,121,407 |
I/I |
1,888,519 |
1,888,519 |
0 |
- |
|
HZNP |
Horizon Pharma, Inc. |
Director |
|
2011-08-02 |
4 |
B |
$9.00 |
$2,843,514 |
I/I |
315,946 |
2,204,465 |
2.1 |
- |
|
ZGNX |
Zogenix, Inc. |
Director |
|
2011-09-21 |
4 |
B |
$2.00 |
$2,500,000 |
I/I |
1,250,000 |
5,321,546 |
2.1 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2014-11-12 |
4 |
B |
$5.57 |
$150,544 |
D/D |
27,052 |
27,052 |
2.39 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2014-11-18 |
4 |
B |
$5.58 |
$3,487 |
D/D |
625 |
27,677 |
2.31 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2014-11-18 |
4 |
B |
$5.58 |
$3,905 |
I/I |
700 |
700 |
2.1 |
- |
|
28 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|